, Volume 7, Issue 1, pp 68–74 | Cite as

Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs

  • P. E. Schurr
  • J. R. Schultz
  • T. M. Parkinson


We describe a screening test for hypolipidemic agents in which compounds are administered orally to fasted rats after a single intravenous injection of 225 mg Triton WR-1339/kg and serum cholesterol and triglycerides are measured 43 hr post-Triton. Conditions for the screen were established by studying interrelationships between serum cholesterol, triglycerides and Triton levels during the post-Triton period and the effects of Triton dose, route of administration and fasting on serum lipid levels and drug hypocholesterolemic activity. The test detects compounds which inhibit lipid biosynthesis or stimulate lipid catabolism. Several drugs with different mechanisms of action which are hypolipidemic in man, including nicotinic acid,D-thyroxine, triparanol, nafoxidine HCl and clofibrate are active in this system. Results with standard hypolipidemic agents are reproducible and conform well to performance levels of the screen predicted from statistical analysis.


Cholesterol Nicotinic Acid Serum Cholesterol Clofibrate Desmosterol 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Friedman, M., and S.O. Byers, J. Exp. Med. 97:117 (1953).PubMedCrossRefGoogle Scholar
  2. 2.
    Franz, I.D., and B.T. Hinkelman, J. Exp. Med. 101:225 (1955).CrossRefGoogle Scholar
  3. 3.
    Hirsch, R.L., and A. Kellner, J. Exp. Med. 104:1 (1956).PubMedCrossRefGoogle Scholar
  4. 4.
    Schotz, M.C., A. Scanu and I.H. Page, Amer. J. Physiol. 188:399 (1957).PubMedGoogle Scholar
  5. 5.
    Friedman, M., and S.O. Byers, Ibid. 190:439 (1957).PubMedGoogle Scholar
  6. 6.
    Scanu, A., P. Oriente, J.M. Szajewski, L.J. McCormack and I.H. Page, J. Exp. Med. 114:279 (1961).PubMedCrossRefGoogle Scholar
  7. 7.
    Byers, S.O., M. Friedman and T. Sugiyama, Amer. J. Physiol. 204:1100 (1963).PubMedGoogle Scholar
  8. 8.
    Jorolan, E.P., and B.W. Janicki, Prog. Biochem. Pharmacol. 2:308 (1967).Google Scholar
  9. 9.
    Garattini, S., R. Paoletti, L. Bizzi, E. Grossi and R. Vertua, in “Drugs Affecting Lipid Metabolism,” Edited by S. Garattini and R. Paoletti, Elsevier, Amsterdam. 1961, p. 144.Google Scholar
  10. 10.
    Paoletti, R., Amer. J. Clin. Nutr. 10:277 (1962).PubMedGoogle Scholar
  11. 11.
    Phillips, W.A. and C.P. Berg, J. Nutr. 53:481 (1954).PubMedGoogle Scholar
  12. 12.
    Zak, B., N. Moss, A.J. Boyle and A. Zlatkis, Anal. Chem. 26:776 (1954).CrossRefGoogle Scholar
  13. 13.
    Royer, M.E., and H. Ko, Anal. Biochem. 29:405 (1969).PubMedCrossRefGoogle Scholar
  14. 14.
    Cornforth, J.W., P. D'arcy Hart, R.J.W. Lees and J.A. Stock, Nature 108:150 (1951).CrossRefGoogle Scholar
  15. 15.
    Steel, R.G.D., and J.H. Torrie, in “Principles and Procedures of Statistics,” McGraw-Hill, New York, 1960, p. 106.Google Scholar
  16. 16.
    Pearson, E.S., and H.O. Hartley, Biometrika 38:112 (1951).PubMedCrossRefGoogle Scholar
  17. 17.
    Tiku, M.L., J. Amer. Statist. Ass. 62:525 (1967).CrossRefGoogle Scholar
  18. 18.
    Carlson, L.A., and L. Oro, J. Atheroscler. Res. 4:436 (1965).CrossRefGoogle Scholar
  19. 19.
    Kritchevsky, D., Metabolism 9:984 (1960).PubMedGoogle Scholar
  20. 20.
    Phillips, W.A., and P.E. Schurr, Federat. Proc. 26: Abstract 2222 (1967).Google Scholar
  21. 21.
    Avoy, D.R., E.A. Swyryd and R.G. Gould, J. Lipid Res. 6:369 (1965).PubMedGoogle Scholar
  22. 22.
    Steinberg, D., and J. Avigan, J. Biol. Chem. 235:3127 (1960).Google Scholar
  23. 23.
    Riggi, S.J., and N.R. DiLuzio, J. Lipid Res. 3:339 (1962).Google Scholar
  24. 24.
    Blickens, D.A., and N.R. DiLuzio, J. Reticuloendothel. Soc. 1:68 (1964).Google Scholar

Copyright information

© American Oil Chemists’ Society 1972

Authors and Affiliations

  • P. E. Schurr
    • 1
  • J. R. Schultz
    • 1
  • T. M. Parkinson
    • 1
  1. 1.Research LaboratoriesThe Upjohn CompanyKalamazoo

Personalised recommendations